The Effect of Prematurity and Hypertensive Disorders of Pregnancy on Offspring Cardiovascular Health (EPOCH)
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
While the incidence of cardiovascular disease has reduced dramatically, coinciding with favourable changes in risk factors, cardiovascular disease remains the single largest cause of mortality and premature mortality in the United Kingdom. Identification of novel biological pathways that underlie disease susceptibility raises the potential for new early primary prevention strategies to complement classical management. There is particular interest in the role of early environment in 'programming' risk of cardiovascular disease in later life and growing evidence that various early life exposures impact cardiovascular health in the longer term.
The investigators have therefore designed the EPOCH study to investigate whether those individuals born to hypertensive pregnancies and/or to a preterm birth demonstrate differences in the cardiovascular phenotype at birth, or whether they develop any differences over the first three months of life and whether this varies with other perinatal factors. This study also allows investigation of the short term impact of perinatal interventions used in this cohort. Comprehensive multi-modality non-invasive imaging measures of cardiovascular structure and function allow precise quantification of cardiovascular phenotype in this population.
Tipo di studio
Iscrizione (Anticipato)
Contatti e Sedi
Contatto studio
- Nome: Paul Leeson, PhD, FRCP
- Numero di telefono: +44(0)1865572846
- Email: paul.leeson@cardiov.ox.ac.uk
Luoghi di studio
-
-
Oxfordshire
-
Oxford, Oxfordshire, Regno Unito, OX3 9DU
- Reclutamento
- Cardiovascular Clinical Research Facility, Dept of Cardiovascular Medicine, University of Oxford
-
Contatto:
- Paul Leeson, PhD, MRCP
- Email: paul.leeson@cardiov.ox.ac.uk
-
Investigatore principale:
- Paul Leeson, PhD, FRCP
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- Available for assessment within the neonatal period,
- Parent is willing and able to give informed consent for participation in the study,
- Physical condition is suitable to allow non-invasive vascular testing,
- Mother meets criteria for inclusion in the study and is willing to participate in the study. (Aged >/= 16 years and Is able and willing to give informed consent for participation in the study, and is able and willing to give informed consent for her infants participation in the study. )
- Cases: Diagnosed during pregnancy with preeclampsia or gestational hypertension and/or delivered preterm (<37 weeks gestation)
- Controls: No history of gestational hypertension or preeclampsia during this pregnancy and delivered at term (>37 weeks gestation)
Exclusion Criteria:
- Parent is unwilling to give consent,
- Unavailable for assessment of cardiovascular system,
- Physical condition unsuitable to allow for non-invasive testing of cardiovascular system,
- Evidence of congenital cardiovascular disease (with the exception of Persistent Patent Ductus Arterious (PDA) and Atrial Septal Defect (ASD)),
- Cardiorespiratory instability at time of proposed measures,
- Active infection at time of proposed study measures,
- Mother of infant is excluded from the study. (Aged <16 years, unable or unwilling to consent to study or Physical condition post delivery such that it would preclude participation in the study)
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
|---|
|
Normotensive Term
Infants born at term (>37 weeks) to Normotensive pregnancies
|
|
Term Preeclampsia
Infants born at term (>37 weeks gestation) and exposed to a preeclamptic pregnancy
|
|
Preterm Normotensive
Infants born to Normotensive pregnancies at <37 weeks gestation
|
|
Preterm Hypertensive
Infants born to hypertensive pregnancies at <37 weeks completed gestation
|
|
Term Pregnancy-induced Hypertension
Infants born at term (>37 weeks gestation) and exposed to pregnancy-induced hypertension
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Systolic Cardiac Function
Lasso di tempo: Birth and 3 months
|
Cardiac Function will be assessed by ECHO at birth and 3 months
|
Birth and 3 months
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Micro-vascular Structure
Lasso di tempo: Birth and 3 months
|
Micro-vascular Structure will be assessed using Side Stream Dark Field (SDF) imaging device at birth and 3 months (as capillary density at baseline)
|
Birth and 3 months
|
|
Pulse wave velocity and pulse-wave analysis
Lasso di tempo: Birth and 3 months
|
Birth and 3 months
|
|
|
Cardiac Structure
Lasso di tempo: Birth and 3 months
|
Cardiac structure will be assessed by echocardiography at in utero, at birth and 3 months (as left and right ventricular mass)
|
Birth and 3 months
|
|
Cardiac diastolic function
Lasso di tempo: Birth and 3 months
|
Cardiac Function will be assessed by ECHO at birth and 3 months
|
Birth and 3 months
|
|
Blood pressure
Lasso di tempo: Birth and 3 months
|
Birth and 3 months
|
|
|
Heart rate variability
Lasso di tempo: Birth and 3 months
|
Heart rate variability will be assessed by a 5 minute electrocardiogram
|
Birth and 3 months
|
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Investigatore principale: Paul Leeson, PhD, FRCP, University of Oxford Department of Cardiovascular Medicine
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Anticipato)
Completamento dello studio (Anticipato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- EPOCH
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .